EAT is up +49.38%% since April’24 pick View All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BIO.DE
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Tuesday for Biotest Aktiengesellschaft
(Updated on Jun 25, 2024)

Sell candidate since Jun 13, 2024 PDF

No changes to the price of Biotest Aktiengesellschaft stock on the last trading day (Tuesday, 25th Jun 2024). During the last trading day the stock fluctuated 0% from a day low at 41.00€ to a day high of 41.00€. The price has been going up and down for this period, and there has been a 0.49% gain for the last 2 weeks.

The stock lies in the middle of a narrow and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.82% during the next 3 months and, with a 90% probability hold a price between 39.46€ and 40.44€ at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BIO.DE Signals & Forecast

There are mixed signals in the stock today. The Biotest Aktiengesellschaft stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at 41.00€ and 41.31€. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Tuesday, June 11, 2024, and so far it has risen 0.490%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Biotest Aktiengesellschaft stock

Biotest Aktiengesellschaft finds support from accumulated volume at 40.80€ and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved 0€ between high and low, or 0%. For the last week the stock has had daily average volatility of 0.493%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BIO.DE) For The Upcoming Trading Day Of Wednesday 26th

For the upcoming trading day on Wednesday, 26th we expect Biotest Aktiengesellschaft to open at 41.00€, and during the day (based on 14 day Average True Range), to move between 40.83€ and 41.17€, which gives a possible trading interval of +/-0.168€ (+/-0.41%) up or down from last closing price. If Biotest Aktiengesellschaft takes out the full calculated possible swing range there will be an estimated 0.82% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at 40.80€ (0.49%) than the resistance at 41.40€ (0.98%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Biotest Aktiengesellschaft stock A Buy?

Biotest Aktiengesellschaft holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.701 Sell Candidate Unchanged

Predicted Opening Price for Biotest Aktiengesellschaft of Wednesday, June 26, 2024

Fair opening price June 26, 2024 Current price
41.00€ ( 0%) 41.00€

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BIO.DE

Fibonacci Support & Resistance Levels

Level Price
R3 41.00 -
R2 41.00 -
R1 41.00 -
Price 41.00
S1 41.00 -
S2 41.00 -
S3 41.00 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 41.80 1.95%
R2 41.60 1.46%
R1 41.40 0.98%
Price 41.00
S1 40.80 -0.488%
S2 0 -
S3 0 -

BIO Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 08, 2024 May 08, 2024 May 10, 2024 0.0400€ 0.0962%
2 May 08, 2019 May 08, 2019 May 08, 2019 0.0400€ 0.163%
3 May 16, 2018 May 16, 2018 May 16, 2018 0.0400€ 0.154%
4 Mar 29, 2017 Aug 31, 2017 Sep 04, 2017 0.0500€ 0.174%
5 Mar 23, 2016 May 13, 2016 May 13, 2016 0.0200€ 0.118%

FAQ

What is the symbol for Biotest Aktiengesellschaft Stock and on which exchange is it traded?
The symbol for Biotest Aktiengesellschaft is BIO.DE and it is traded on the GER (Deutsche Börse XETRA).

Should I buy or sell Biotest Aktiengesellschaft Stock?
Biotest Aktiengesellschaft holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Biotest Aktiengesellschaft Stock?
Biotest Aktiengesellschaft Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Biotest Aktiengesellschaft Stock.

What's the current price of Biotest Aktiengesellschaft Stock?
As of the end of day on the Jun 25, 2024, the price of an Biotest Aktiengesellschaft (BIO.DE) share was 41.00€.

What is the 52-week high and low for Biotest Aktiengesellschaft Stock?
The 52-week high for Biotest Aktiengesellschaft Stock is 44.00€ and the 52-week low is 39.60€.

What is the market capitalization of Biotest Aktiengesellschaft Stock?
As of the Jun 25, 2024, the market capitalization of Biotest Aktiengesellschaft is 1.338B.

When is the next earnings date for Biotest Aktiengesellschaft?
The upcoming earnings date for Biotest Aktiengesellschaft is Jul 30, 2024.
Click to get the best stock tips daily for free!

About Biotest Aktiengesellschaft

Biotest Aktiengesellschaft Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in hematology, clinical immunology, and intensive care medicine areas. Its products include Haemoctin and Vihuma for the treatment of haemophilia A acute therapy and prophylaxis; and Haemonine for haemophilia B acute therapy and prophyl... BIO.DE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT